Balfaxar is indicated for the urgent reversal of acquired coagulation factor deficiency induced by vitamin K antagonist (VKA, e.g., warfarin) therapy in adult patients.
CareALERTS was developed to increase immunization rates among adults and seniors, and in 2023 it successfully increased companion pneumococcal immunizations by 28% among participating pharmacies.